Data Platform

Drug Intelligence SMAART Audit Platform:

Syndicated Metrics, Attitudes & Analysis of Real-World Treatment

Our 20 years of healthcare database expertise provides Real-World Evidence for timely product analysis and longitudinal market insights.

ONCO•CAPPS

Real World Oncology Database

  • Oncology Continuous Audit of Patients and Prescriptions Syndicated; the most comprehensive data for all solid and blood cancers
  • Real-time data on how your product and other competitors are being used
  • Credible data and outcomes to ensure accurate market and forecast assumptions
  • Longitudinal data for Market Access support and pCODR submissions

Market Share Trends

  • Quarterly tracking of oncology products by indication and line of therapy

Patient & Treatment Pathways

  • Map the patient pathway through diagnosis and the disease continuum
  • Chart treatment sequencing
  • Therapeutic selection and population segmentation based on treatment decision at the point of care-in-the-chair
Onco-Capps_V3
Onco-Capps-Biomark_V3

ONCO•CAPPS BIOMARK

Precision Oncology Biomarker Database

  • Real-world testing KPI’s for biomarker-driven therapeutics
  • Biomarker access data for real-time testing strategy
  • Credible biomarker testing rate data to ensure accurate sub-population epidemiology and companion product forecast assumptions

Biomarker Uptake Trends

  • Quarterly tracking of oncology biomarker testing rates by type of biomarker, indication and line of therapy

Biomarker Sample & Treatment Pathways

  • Map the tissue/liquid sample pathway at diagnosis and at recurrence
  • Chart treatment sequencing based on biomarker status through the disease continuum
  • Clinical and system barrier access points to testing rates

RADAR•PLUS

Real World Immunology Database for Inflammatory Diseases

  • Rheumatology Audit of Drug Treatment And Response; PLUS the most comprehensive data for all inflammation diseases in dermatology and gastroenterology
  • Real-time data on how your product and other competitors are being utilized
  • Credible data and outcomes to ensure accurate market and forecast assumptions
  • Longitudinal data for market access support and payer submissions

Market Share Trends by Indication

  • Quarterly tracking of inflammation products use by indication and line of therapy

Patient & Treatment Pathways

  • Map the patient pathway through diagnosis and the disease continuum
  • Chart treatment sequencing
  • Therapeutic selection and population segmentation based on treatment decision at the point of care-in-the-chair
radar-plus_V4
Hep-C_V4

HEP•C

Real World Chronic Hepatitis C Database 

  • Real-time use of how your product and other competitors are being utilized
  • Credible usage and outcomes data to ensure accurate market and forecast assumptions
  • Longitudinal data on duration of treatment and clinical outcomes
  • Rational for initiating/switching treatment regimens

Market Share Trends

  • Quarterly tracking of HEP-C products by indication and line of therapy

Patient & Treatment Pathways

  • Map the patient pathway through diagnosis and the disease continuum
  • Relevant clinical influencing factors impacting treatment decision
  • Detailed patient demographics, risk profiles and drug usage profiles

PRIME

Real World Practice Database for Primary Care

  • Diabetes, Cardiovascular, Anti-coagulants
  • Respiratory
  • Mental Health, Migraine, ADHD
  • Bone Health
  • Vaccines and Infectious Disease
  • Endocrinology
  • Neurology
  • Adult and Pediatric conditions
  • Real-time data on how your product and other competitors are being utilized
  • Credible data and outcomes to ensure accurate market and forecast assumptions
  • Longitudinal data for market access support and payer submissions

Market Share Trends by Indication

  • Quarterly tracking of primary care products use by indication and line of therapy

Patient & Treatment Pathways
  • Map the patient pathway through diagnosis and the disease continuum
  •  Chart treatment sequencing
  • Therapeutic selection and population segmentation based on treatment decision at the point of care-in-the-chair
prime-v2
sport-sa-v2

SPORT•SA

Real World Hospital Drug Use by Indication

  • All drug categories
  • Oral & Injectable
  • Drug use by physician type
  • In-patient drug management: dose, frequency, duration
  • Concurrent treatments
  • Operating Room & Anesthesia
  • Surgical procedures
  • Post hospital discharge treatment
  • Number of cases by diagnosis

NEPHRO•CAPPS

Real World Nephrology Database

  • Nephrology Continuous Audit of Patients and Prescriptions Syndicated; the most comprehensive database in the continuum of Chronic Kidney Disease (CKD) and dialysis
  • Real-world practice data on the management of complications associated with CKD and End-Stage renal disease (ESRD)
  • Comprehensive drug usage and sequencing profiles throughout CKD/ESRD stages

Patient & Treatment Pathways

  • Map the patient pathway through diagnosis and the disease continuum
  • Relevant clinical influencing factors impacting treatment decision
  • Detailed patient and drug usage profiles
NEPHRO_V3